The GI Cancer Institute saves lives by funding gastro-intestinal cancer research.
Gastro-Intestinal (GI) cancers include those of the oesophagus, stomach, liver, gall bladder, pancreas, small intestine, bowel and anus. GI cancers are the most common form of cancer, directly affecting more than 24,000 Australians each year and claiming a devastating 33 lives each day.
Our clinical trials allow us to find better ways to treat GI cancers. This has seen improvement in both the life expectancy and quality of life of people diagnosed with these cancers. Donations are used to fund clinical trials research by the not-for-profit organisation Australasian Gastro-Intestinal Trials Group (AGITG).